date:May 15, 2014
other metabolic functions. The findings from the first clinical trial of the pure compound, which were presented in September 2012 at the American Heart Association's High Blood Pressure Research 2012 Scientific Sessions, showed that pTeroPure (pterostilbene) significantly reduced blood pressure in adults. pTeroPure was named the 2010 North American Most Promising Ingredient of the Year by the independent research company Frost Sullivan.